Introduction
Ageing is associated with a decline in physical performance that negatively affects quality of life and may compromise independence [1, 2] . The assessment of physical performance is a critical component of older people's health. For example, the summary of physical performance scores has been shown to be useful in the prediction of institutionalisation, disability and mortality [3] . A biological mechanism recently proposed to underlie the decline in physical performance is chronic inflammation [4] . Inflammation is the body's integrated reaction and defence against disturbances of homeostasis, particularly infections and injuries. Ageing is associated with a chronic lowgrade inflammation and increased production of inflammatory cytokines [4, 5] . Cytokines are also involved in numerous physiological functions, such as muscle and bone tissue turnover, immunoregulation and haematopoiesis; in addition, their circulating levels have been found to relate to several diseases [6] .
Most [6] [7] [8] [9] but not all [10] studies in developed world show cross-sectional association between CRP and physical performance. We examined the association between CRP and physical performance among middle-aged and older people in the context of a low-income country. Evidence of an association between inflammatory markers and physical performance in middle age would support the hypothesis that inflammation is involved in the pathogenesis of preclinical physical performance decline. This study aims to assess whether serum concentrations of CRP are associated with low physical performance among middle-aged (40-54 years old) and older people (55-96 years old), using the measure of activities of daily living (ADL) in Indonesia. To achieve this, we used data from the Indonesian Family Life Survey 2007.
Methods The Indonesian family life survey 2007
The Indonesian Family Life Survey (IFLS) is an ongoing longitudinal survey in Indonesia. The sample of households represented 83% of the Indonesian population living in the 13 provinces in 1993 [11] . In this study, we used data from the fourth (2007) round of the IFLS, the only round that collects inflammatory markers [11, 12] . The data were weighted using cross-sectional person sampling weights based on age and sex provided in the IFLS datasets for 2007.
In total, there are 9,945 observations with C-reactive protein data for the sample, which includes individuals ranging from 15 to 96 years old. In this study, we used respondents who had completed information on ADL and CRP data. In total, there were 1,702 respondents of middle age (age 40-54) and 2,017 older respondents (age 55-96). Missing response was quite low with 3% for middle age respondent and 1% for old respondent.
Physical performance measures
This study used activities of daily living to measure physical performance. ADL refer to the basic tasks of everyday life, such as eating, bathing, dressing, toileting and transferring [13] . Measurement of ADL is critical, because these measurements have been found to be significant predictors of nursing home admission [14] ; use of paid home care [15] ; use of hospital services [16] ; living arrangements [17] ; use of physician services [18] ; insurance coverage [19] ; and mortality [20] . In the literature on ageing, the ability to perform ADL has become one of the standard indicators to measure health status, which provides objective data that may indicate future decline or improvement in health status, allowing healthcare providers to plan and intervene appropriately [13, 21] .
The IFLS used 13 items of ADL adapted from the US Health and Retirement Study (1992) [13, 22] . Respondents age 40 years and older were asked whether they were able to perform these activities easily (coding = 3), with difficulty (coding = 2) or unable to do so (coding = 1). The resulting ADL score was the total sum of respondents' answers [13] .
Inflammatory markers
Respondents were asked for fasting before CRP blood test. CRP concentrations in dried blood spot specimens were measured, using validated enzyme-linked immunosorbent assay (ELISA) method. The details of CRP data collection and validation in IFLS 2007 are explained in the IFLS C-Reactive Protein Data User Guide [12] .
Potential confounders and sociodemographic control variables
Potential confounders include co-morbid conditions, overweight/obesity, total cholesterol level and use of medication for diabetes, cholesterol and/or hypertension. Co-morbid conditions were measured as the sum of doctor's diagnoses of hypertension, diabetes, asthma, stroke, angina, liver disease, cancer, gout and/or arthritis. Infectious diseases such as tuberculosis, cholera and fever were also included in the model to control whether the prevalence of these diseases affects ADL. An infectious disease was measured by the sum of doctor's diagnoses of those diseases. In addition, we included a validated measure of depressive symptoms (CES-D) to control whether the mental health of respondents was associated with physical performance [23] . A dummy variable indicating respondents have smoking habit was included as an indicator of health risk.
Individual and household sociodemographic characteristics included age, gender, marital status, education, household expenditure, social participation and location in urban or rural areas. Age is included to capture whether the age gradient relates to ADL. Education and household expenditure are continuous variables. Education was measured by respondent's years of schooling. Household monthly expenditure was used to control whether household economic status relates to ADL. Household monthly expenditure was logged to make the distribution more symmetric and reduces the effect of outliers. Social participation was measured by the sum of respondent's participation in community activities. The detailed information of potential confounders and sociodemographic control variables is explained in Supplementary data, Table S3 , available in Age and Ageing online.
Statistical analysis
Since the distribution of CRP was not normal, analyses were performed using its log values [6] . Spearman's correlation tests were used to evaluate bivariate correlations of inflammatory markers with physical performance. For multivariate analyses, three-level linear regressions were applied to take full advantage of the household and community clustering information available from the IFLS. Analyses were adjusted for sociodemographic variables, health risks, mental health and co-morbid conditions. We carried out three-level linear regression using the Stata 13.0 software [24] . First the relationship between CRP and ADL is shown, followed by including co-morbidities and infectious diseases, then by including other potential confounders and lastly by including sociodemographic characteristics. The models were also undertaken by including sociodemographic variables first; however, the results were similar.
Results
Data from 1,702 middle-aged participants (61% female) and 2,017 (53% female) older participants were analysed ( Table 1) . The mean age among the middle-aged respondents was 48 years (SD 4.3, range 40-54 years), whereas the mean age of the older respondents was 65 years (SD 7.3, range 55-96 years). The majority of the population were non-smokers (68% for middle-aged people and 56% for older people, respectively) with a moderately number of infectious diseases prevalence (mean 0.36, SD 0.612 for middle-aged people; mean 0.41, SD 0.615 for older people). The most common diagnoses reported by respondents were hypertension (17% for middle-aged people and 23% for older people). The ADL scores of older people were lower than those of middle-aged people (mean 38.2, SD 1.531, range 25-39 and mean 36.67, SD 3.452, range 13-39, respectively). The CRPs of middle-aged people were lower than those of older people (mean 0.68, SD 1.183, range 0.10-13.49 versus mean 0.73, SD 1.252, range 0.40-13.54).
Bivariate Spearman's correlations between inflammatory markers and physical performance are given in Table 1 (column three for middle-aged people and column five for older people). The CRP is significantly associated with ADL (r = −0.108 for middle-aged people and r = −0.133 for older people). Significant correlations were also found for comorbid conditions, infectious diseases, smoking behaviour, medication and CES-D.
The three-level regression results for the association of CRP with ADL for middle-aged people are given in Table 2 . High levels of CRP were associated with lower ADL (ß = −0.712, P < 0.001). When the models were adjusted for co-morbid conditions and infectious diseases, CRP was still significantly associated with poor ADL (ß = −0.623, P < 0.001). The association remained significant when the model was adjusted to account for smoking behaviour, medication and CES-D (ß = −0.596, P < 0.001). The significant association between CRP and ADL was maintained in the final model (Model 4), where potential confounders and sociodemographic characteristics were included (ß = −0.505, P < 0.001). Table 3 presents the results of the three-level linear regression for the association of CRP with ADL among older people. High levels of CRP were associated with lower ADL (ß = −1.065, P < 0.001). When the models were adjusted for co-morbid conditions and infectious diseases, high levels of CRP were still significantly associated with poor ADL (ß = −0.927, P < 0.001). The association remained significant when the model was adjusted to account for smoking behaviour, medication and CES-D (ß = −0.870, P < 0.001). The significant association between CRP and ADL was maintained in the final model (Model 4), where potential confounders and sociodemographic characteristics were included (ß = −0.659, P < 0.001).
Most of the potential confounders and sociodemographic characteristics show significant associations with ADL for both age groups. As more covariates are included into the model, the likelihood or fit of the model improves (the log likelihood increases). Thus, co-morbid conditions and infectious diseases are significant risk factors for poor ADL in both samples. Also significant effects of total cholesterol and obesity on ADL were found in both samples. Smoking is unsurprisingly associated with reduced physical performance. Higher CES-D is associated with lower ADL in both middle-aged and older people.
Sensitivity analyses
Following Lima et al., we exclude those with a CRP level >10 mg/1 indicating acute inflammation; this gives broadly similar coefficients for the association between CRP and ADL in both middle-aged and older populations, suggesting robust results [28] (Supplementary data, Tables S1 and S2, available in Age and Ageing online).
Discussion
This study examines the association between CRP and physical performance among middle-aged and older people in Indonesia. Although recent studies have suggested that inflammation may play an important role in the process of ageing and in the development of disabilities, knowledge about the role of inflammation in physical performance decline among middle-aged and older people in lower-income countries is limited. Our results showed that high levels of CRP were significantly associated with lower ADL for middle-aged (40-54 years) and older people (55-96 years).
Our results are in line with earlier studies [6, 8, 9] and provide an extension thereof: previous studies generally examined people aged 55 years and older. Our findings show that in a low-income country, the significant association between CRP and physical performance is also found in middle-aged participants (40-54 years).
Explanations for the associations between inflammation and functional limitation are still unclear. Several studies have shown that elevated levels between inflammatory markers are associated with many different diseases [25, 26] . It is unclear whether elevated levels of inflammatory markers result from chronic diseases or markers of chronic diseases that have an effect on functional performance or if inflammatory markers have their own effect on the ageing process. Elevated inflammation levels might not be a necessary consequence of ageing; rather, they could be due to the increased number and accumulated effects of the diseases from which people suffer [4] . Chronic diseases have long-term effects on one's ability to manage everyday life, effectively causing functional disabilities. Inflammatory biomarkers have catabolic effects on muscle, and via that pathway, they may cause a decline in physical functioning [4] , which can again cause decreased muscle strength. It could also be that inflammatory markers are more than simply risk factors for age-related diseases; they may illustrate the links between lifestyle factors, infectious diseases and the physiological changes that take place during the ageing process [5] .
A primary strength of our study is that the populationbased sample enhances the generalisability of the study's findings and reduces the potential for selection bias [27] . This study demonstrates the utility of collecting and using CRP measures among a population-based sample in developing countries [13] . Limitations of the study include its crosssectional design that did not allow us to determine the causal direction of the observed association between inflammatory markers and physical function. Further investigation aimed at assessing the predictive value of inflammatory marker levels on physical function and its decline is needed especially in the context of developing countries. Another limitation may be found in the circadian variability characteristic of cytokines. However, most of the blood sampling was done at the same time in the morning, limiting this potential source of bias.
Evidence of an association between CRP and physical performance in middle age supports the hypothesis that inflammation is involved in the pathogenesis of preclinical physical performance decline. These findings suggest the importance of targeting inflammation beginning in middle age to reduce disability in older age. Policies aimed at preventing inflammation, such as maintenance of a good diet, exercise and the promotion of healthy living among middle-aged people will defer the onset of the impairment already evidenced in Indonesians at midlife.
Key points
• CRP associated with ADL of middle-aged and old people, robust with co-morbidity conditions, robust with sociodemographic characteristics.
• Based on population sample, and Indonesia.
